COMMUNIQUÉS West-GlobeNewswire

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
30/04/2026
New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DME Key data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing treatment burden [...]
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update
30/04/2026
GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease models Continued to reposition dipraglurant mGlu5 NAM for brain injury recovery Entered [...]
Valneva annonce le succès d’une Offre Réservée d’un montant de 84 millions d’euros
30/04/2026
Lyon (France), le 30 avril 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (« Valneva » ou la « Société »), société spécialisée dans les vaccins, annonce le succès d’une offre réservée d’un montant de 84 millions [...]
Vaccinex Reports 2025 Annual Financial Results
30/04/2026
ROCHESTER, N.Y., April 29, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTCMKTS:VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in Alzheimer’s, Huntington’s disease, and [...]
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million
30/04/2026
Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited ( [...]
Avalyn Announces Pricing of Upsized Initial Public Offering
30/04/2026
BOSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) (“Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare [...]
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
29/04/2026
RECELL GO ® receives regulatory clearance in Australia and New Zealand, enabling commercialization across both markets RECELL GO is AVITA Medical’s next-generation system that automates and standardizes the preparation [...]
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
29/04/2026
CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients [...]
Teladoc Health Reports First Quarter 2026 Results
29/04/2026
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First Quarter 2026”). [...]
MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026
29/04/2026
ROCKVILLE, Md., April 29, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
29/04/2026
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the [...]
LifeStance to Present at Upcoming Investor Conferences
29/04/2026
SCOTTSDALE, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced that management will present at [...]
Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
29/04/2026
IRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, May 6, 2026 to report its [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29/04/2026
MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026
30/04/2026
LOUISVILLE, Ky., April 29, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, [...]
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
29/04/2026
TLX597-Tx is a PSMA 1 -targeting small molecule radioligand therapy (RLT) candidate, designed to improve quality-of-life and efficacy in earlier-stage prostate cancer. OPTIMAL-PSMA 2 initial dosimetry data demonstrate [...]
RxSight, Inc. to Present at the Bank of America Healthcare Conference
29/04/2026
ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside [...]
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
29/04/2026
ASCEND Phase 1/2 global clinical trial ongoing, evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types in first-line and previously treated patients; first ADC combination trial with CR-001 [...]
Serotonin Centers Opens Second North Texas Location in Fort Worth, Expanding Physician-Led Longevity Care
29/04/2026
New Center Builds on Strong Demand in Dallas–Fort Worth for Hormone Optimization, Medical Weight Loss and Proactive Health FORT WORTH, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in [...]

Pages